FDA Inspection 1180888 — American Natl. Red Cross-Greater Chesapeake & Potomac Region
The FDA completed an inspection of American Natl. Red Cross-Greater Chesapeake & Potomac Region on September 12, 2022 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 12, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Baltimore, MD (United States)